4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-018816
Chief Executive Officer acquired 1,091,299 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carpenter George C IV Chief Executive Officer | 2013-03-27 | Option exercise | +1,091,299 | $0.05 | $51,509 | 1,159,549 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Carpenter George C IV Chief Executive Officer | 2013-03-27 | Option exercise · Convertible Note | −50,000 | 0 | D: show line 2 in the form |
Loading xslF345X03/v339978_form4.xml…